期刊文献+

Case report of a healthy,elderly man with long-term high titers for anti-acetylcholine receptor antibody without myasthenia gravis

Case report of a healthy,elderly man with long-term high titers for anti-acetylcholine receptor antibody without myasthenia gravis
下载PDF
导出
摘要 Anti-acetylcholine receptor antibodies (AAR) are considered pathognomonic and pathogenetic for myasthenia gravis (MG). AAR detection confirms clinical diagnosis of MG. However, AAR is rarely detected in patients without MG. The underlying pathophysiological mechanisms in a normal subject without MG have not been adequately addressed in previous studies. The present study reports on a case study of a healthy, elderly man with high AAR titers for 14 years. Pathophysiological mechanisms could be due to AAR heterogeneity in specificity, affinity, and multiform, and to muscle variability in response to AAR. Anti-acetylcholine receptor antibodies (AAR) are considered pathognomonic and pathogenetic for myasthenia gravis (MG). AAR detection confirms clinical diagnosis of MG. However, AAR is rarely detected in patients without MG. The underlying pathophysiological mechanisms in a normal subject without MG have not been adequately addressed in previous studies. The present study reports on a case study of a healthy, elderly man with high AAR titers for 14 years. Pathophysiological mechanisms could be due to AAR heterogeneity in specificity, affinity, and multiform, and to muscle variability in response to AAR.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2010年第23期1832-1835,共4页 中国神经再生研究(英文版)
关键词 myasthenia gravis anti-acetylcholine receptor antibody false-positive antibody autoimmune disorder myasthenia gravis anti-acetylcholine receptor antibody false-positive antibody autoimmune disorder
  • 相关文献

参考文献30

  • 1Benatar M.A systematic review of diagnostic studies in myasthenia gravis.Neuromuscular Dis.2006;16:459-467.
  • 2Howard FM Jr,Lennon VA,Finley J,et al.Clinical correlations of antibodies that bind,block,or modulate human acetylcholine receptors in myasthenia gravis.Ann N Y Acad Sci.1987;505:526-538.
  • 3Meriggioli MN,Howard JF,Harper CM.Diagnostic tests for neuromuscular junction disorders.In:Meriggioli MN,Howard JF,Harper CM,eds.Neuromuscular Junction Disorders:Diagnosis and Treatment.New York:Informa Healthcare.2004:59-95.
  • 4Somnier FE.Clinical implementation of anti-acetylcholine receptor antibodies.J Neurol Neurosurg Psychiatry.1993; 56:496-504.
  • 5Pirskanen R,Bergstrom K,Hammarstrom L,et al.Neuromuscular safety margin:genetical,immunological and electrophysiological determinants in relatives of myasthenic patients:a preliminary report.Ann NY Acad Sci.1981;377:606-613.
  • 6Ohta M,Itoh M,Hara H,et al.Anti-skeletal muscle and anti-acetylcholine recep-tor antibodies in patients with thymoma without myasthenia gravis:relation to the onset of myasthenia gravis.Clin Chim Acta.1991;201:201-206.
  • 7Skeie GO,Apostolski S,Evoli A,et al.Guidelines for the treatment of autoimmune neuromuscular transmission disorders.Eur J Neurol.2006;13:691-699.
  • 8Lennon VA,Griesmann GE.Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis.Neurology.1989;39:1069-1076.
  • 9Lennon VA,Lambert EH,Leiby KR,et al.Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis.J Immunol.1991;146:2245-2248.
  • 10Zaja F,Barillari G,Russo D,et al.Myasthenia gravis after allogeneic bone marrow transplantation.A case report and a review of the literature.Acta Neurol Scand.1997;96:256-259.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部